Login

Switch On Your HIV Smarts.

Predicting HIV Rebound: Progress in HIV Cure Research

Predicting HIV Rebound: Progress in HIV Cure Research

April 30, 2015, by

When HIV treatment is stopped, viral load rebounds. New research that can predict viral load rebound might prove useful for researchers working on an HIV cure. Read More

Capping Coinsurance Payments for PrEP and HIV Meds

Capping Coinsurance Payments for PrEP and HIV Meds

April 29, 2015, by

Covered California will soon vote on capping the amount consumers have to pay for drugs in the “specialty” tier. Two experts explain what this will mean for people paying for HIV medications and Truvada for PrEP. Read More

DHHS: Atripla No Longer Recommended as First-Line HIV Therapy

DHHS: Atripla No Longer Recommended as First-Line HIV Therapy

April 28, 2015, by

The U.S. Department of Health and Human Services recently demoted the widely-used HIV combination pill Atripla from first-line HIV therapy recommendations, not because of a problem with the drug itself, but because of the changing landscape in HIV treatment. Read More

Blocking PD-1: Progress in HIV Cure Research

Blocking PD-1: Progress in HIV Cure Research

April 23, 2015, by

Blocking a signaling molecule called PD-1 on immune cells is one way researchers are reducing HIV viral load and improving immune system function in monkeys. Find out what role this strategy might play in the search for an HIV cure. Read More

Meth, Crack, Coke & Ecstasy: Effects on HIV Disease Progression

Meth, Crack, Coke & Ecstasy: Effects on HIV Disease Progression

April 20, 2015, by

For the first time, a study investigates whether stimulants lead to poorer health outcomes for people with HIV—independent of antiretroviral use. Read More